IMO, Gilead and others will keep their drugs priced high in order to keep earnings projections high. Once their stock finally collapses in price, they will cut the price substantially, and insurance companies will start to treat more patients, which will cause the stock to rally and the executives can sell their stock and make millions again. For Gilead executives it's all about cashing out their stock and options. They can only sell so many shares in a given time period. They simply have no concern for patients. Neither do the other drug companies.
Gt 1a, F0, VL 6.5 million, AST 59, ALT 62
Started Twinvir 1/15/16
6 wk. labs VL UND, AST 27, ALT 20
EOT labs VL UND, AST 23, ALT 19
SVR 16, VL UND, AST 28, ALT 17
SVR 24 , VL UND, 10/8/16
SVR 125, VL UND, 9/22/18
SVR 230, VL UND, 10/3/20